Pieter Reitsma - Selected Publications#

Google Scholar H-index 92 (43,217 citations, i10-index 315)

Reitsma, P.H., P.G. Rothberg, S.M. Astrin, J. Trial, Z. Bar-Shavit, A. Hall, S.L. Teitelbaum, and A.J. Kahn, Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature, 1983. 306(5942): p. 492-4. cited 555 times

Bertina, R.M., B.P.C. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, H. De Ronde, P.A. Van der Velden, and P.H. Reitsma, Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994. 369: p. 64-67. cited 5284 times

Rosendaal, F.R., T. Koster, J.P. Vandenbroucke, and P.H. Reitsma, High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 1995. 85: p. 1504-1508. cited 1412 times

Poort, S.R., F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina, A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 1996. 88(10): p. 3698-703. cited 4092 times

Rosendaal, F.R. and P.H. Reitsma, Genetics of venous thrombosis. J Thromb Haemost, 2009. 7 Suppl 1: p. 301-4. cited 403 times

Van den Berg, Y.W., S. Osanto, P.H. Reitsma, and H.H. Versteeg, The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood, 2012. 119(4): p. 924-32. cited 375 times

Versteeg, H.H., J.W. Heemskerk, M. Levi, and P.H. Reitsma, New fundamentals in hemostasis. Physiol Rev, 2013. 93(1): p. 327-58. cited 1167 times

Verhoef D, Visscher KM, Vosmeer CR, Cheung KL, Reitsma PH, Geerke DP, Bos MHA. Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors. Nat Commun. 2017. 8(1):528. cited 35 times

Schreuder M, Reitsma PH, Bos MHA. Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding. J Thromb Haemost. 2019. 17(8):1229-1239. cited 34 times

Rietveld IM, Lijfering WM, le Cessie S, Bos MHA, Rosendaal FR, Reitsma PH, Cannegieter SC. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. J Thromb Haemost. 2019. 17(1):99-109. cited 75 times